MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.

Vol. 55, Issue 3, 432-443, March 1999

Regulation of alpha 4beta 2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C

Catherine P. Fenster, Matthew L. Beckman, Julie C. Parker, Elise B. Sheffield, Terri L. Whitworth, Michael W. Quick, and Robin A. J. Lester

Department of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama

Neuronal nicotinic acetylcholine receptor (nAChR) desensitization is hypothesized to be a trigger for long-term changes in receptor number and function observed after chronic administration of nicotine at levels similar to those found in persons who use tobacco. Factors that regulate desensitization could potentially influence the outcome of long-lasting exposure to nicotine. The roles of Ca2+ and protein kinase C (PKC) on desensitization of alpha 4beta 2 nAChRs expressed in Xenopus laevis oocytes were investigated. Nicotine-induced (300 nM; 30 min) desensitization of alpha 4beta 2 receptors in the presence of Ca2+ developed in a biphasic manner with fast and slow exponential time constants of tau f = 1.4 min (65% relative amplitude) and tau s = 17 min, respectively. Recovery from desensitization was reasonably well described by a single exponential with tau rec = 43 min. Recovery was largely eliminated after replacement of external Ca2+ with Ba2+ and slowed by calphostin C (tau rec = 48 min), an inhibitor of PKC. Conversely, the rate of recovery was enhanced by phorbol-12-myristate-13-acetate (tau rec = 14 min), a PKC activator, or by cyclosporin A (with tau rec = 8 min), a phosphatase inhibitor. alpha 4beta 2 receptors containing a mutant alpha 4 subunit that lacks a consensus PKC phosphorylation site exhibited little recovery from desensitization. Based on a two-desensitized-state cyclical model, it is proposed that after prolonged nicotine treatment, alpha 4beta 2 nAChRs accumulate in a "deep" desensitized state, from which recovery is very slow. We suggest that PKC-dependent phosphorylation of alpha 4 subunits changes the rates governing the transitions from "deep" to "shallow" desensitized conformations and effectively increases the overall rate of recovery from desensitization. Long-lasting dephosphorylation may underlie the "permanent" inactivation of alpha 4beta 2 receptors observed after chronic nicotine treatment.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J.-C. Hoda, W. Gu, M. Friedli, H. A. Phillips, S. Bertrand, S. E. Antonarakis, D. Goudie, R. Roberts, I. E. Scheffer, C. Marini, et al.
Human Nocturnal Frontal Lobe Epilepsy: Pharmocogenomic Profiles of Pathogenic Nicotinic Acetylcholine Receptor {beta}-Subunit Mutations outside the Ion Channel Pore
Mol. Pharmacol., August 1, 2008; 74(2): 379 - 391.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. LINDSTROM, J. LUO, and A. KURYATOV
Myasthenia Gravis and the Tops and Bottoms of AChRs: Antigenic Structure of the MIR and Specific Immunosuppression of EAMG Using AChR Cytoplasmic Domains
Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Spivak, C. R. Lupica, and M. Oz
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
X. Guo and R. A. J. Lester
Regulation of Nicotinic Acetylcholine Receptor Desensitization by Ca2+
J Neurophysiol, January 1, 2007; 97(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. P. Lau, L. Li, A. J. Merched, A. L. Zhang, K. W.S. Ko, and L. Chan
Nicotine Induces Proinflammatory Responses in Macrophages and the Aorta Leading to Acceleration of Atherosclerosis in Low-Density Lipoprotein Receptor-/- Mice
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 143 - 149.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom
Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human {alpha}4{beta}2 Acetylcholine Receptors
Mol. Pharmacol., December 1, 2005; 68(6): 1839 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. L. Parish, J. Nunan, D. I. Finkelstein, F. N. McNamara, J. Y. Wong, J. L. Waddington, R. M. Brown, A. J. Lawrence, M. K. Horne, and J. Drago
Mice Lacking the {alpha}4 Nicotinic Receptor Subunit Fail to Modulate Dopaminergic Neuronal Arbors and Possess Impaired Dopamine Transporter Function
Mol. Pharmacol., November 1, 2005; 68(5): 1376 - 1386.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. C Klein and J. L Yakel
Paired-pulse potentiation of {alpha}7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurones
J. Physiol., November 1, 2005; 568(3): 881 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-P. Kuo, L. Xu, J. B. Eaton, L. Zhao, J. Wu, and R. J. Lukas
Roles for Nicotinic Acetylcholine Receptor Subunit Large Cytoplasmic Loop Sequences in Receptor Expression and Function
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 455 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
J. Neurosci., June 8, 2005; 25(23): 5563 - 5572.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. M. Braga, E. F. R. Pereira, A. Mike, and E. X. Albuquerque
Pb2+ via Protein Kinase C Inhibits Nicotinic Cholinergic Modulation of Synaptic Transmission in the Hippocampus
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 700 - 710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wu, Y.-P. Kuo, A. A. George, L. Xu, J. Hu, and R. J. Lukas
{beta}-Amyloid Directly Inhibits Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Heterologously Expressed in Human SH-EP1 Cells
J. Biol. Chem., September 3, 2004; 279(36): 37842 - 37851.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, M. E. Dickinson, S. McKinney, M. Jareb, C. Labarca, S. E. Fraser, and H. A. Lester
Assembly of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons
J. Neurosci., December 17, 2003; 23(37): 11554 - 11567.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. R. Stevens, S. R. Krueger, R. M. Fitzsimonds, and M. R. Picciotto
Neuroprotection by Nicotine in Mouse Primary Cortical Cultures Involves Activation of Calcineurin and L-Type Calcium Channel Inactivation
J. Neurosci., November 5, 2003; 23(31): 10093 - 10099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Khiroug, R. Giniatullin, R. C. Klein, D. Fayuk, and J. L. Yakel
Functional Mapping and Ca2+ Regulation of Nicotinic Acetylcholine Receptor Channels in Rat Hippocampal CA1 Neurons
J. Neurosci., October 8, 2003; 23(27): 9024 - 9031.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. M. LINDSTROM
Nicotinic Acetylcholine Receptors of Muscles and Nerves: Comparison of Their Structures, Functional Roles, and Vulnerability to Pathology
Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 41 - 52.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. N. Brown and J. J. Galligan
Muscarinic receptors couple to modulation of nicotinic ACh receptor desensitization in myenteric neurons
Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G37 - G44.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Nelson, A. Kuryatov, C. H. Choi, Y. Zhou, and J. Lindstrom
Alternate Stoichiometries of alpha 4beta 2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., February 1, 2003; 63(2): 332 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. L. Gentry, L. H. Wilkins Jr., and R. J. Lukas
Effects of Prolonged Nicotinic Ligand Exposure on Function of Heterologously Expressed, Human alpha 4beta 2- and alpha 4beta 4-Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. M. Gomez, R. A. Maselli, J. Groshong, R. Zayas, R. L. Wollmann, T. Cens, and P. Charnet
Active Calcium Accumulation Underlies Severe Weakness in a Panel of Mice with Slow-Channel Syndrome
J. Neurosci., August 1, 2002; 22(15): 6447 - 6457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Dobelis, M. J. Marks, P. Whiteaker, S. A. Balogh, A. C. Collins, and J. A. Stitzel
A Polymorphism in the Mouse Neuronal alpha 4 Nicotinic Receptor Subunit Results in An Alteration in Receptor Function
Mol. Pharmacol., August 1, 2002; 62(2): 334 - 342.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Du and L. W. Role
Differential Modulation of Nicotinic Acetylcholine Receptor Subtypes and Synaptic Transmission in Chick Sympathetic Ganglia by PGE2
J Neurophysiol, June 1, 2001; 85(6): 2498 - 2508.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci., March 15, 2001; 21(6): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Narahashi, C. P. Fenster, M. W. Quick, R. A. J. Lester, W. Marszalec, G. L. Aistrup, D. B. Sattelle, B. R. Martin, and E. D. Levin
Symposium Overview: Mechanism of Action of Nicotine on Neuronal Acetylcholine Receptors, from Molecule to Behavior
Toxicol. Sci., October 1, 2000; 57(2): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Fenster, T. L. Whitworth, E. B. Sheffield, M. W. Quick, and R. A. J. Lester
Upregulation of Surface alpha 4beta 2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine
J. Neurosci., June 15, 1999; 19(12): 4804 - 4814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Eddins, L. K. Lyford, J. W. Lee, S. A. Desai, and R. L. Rosenberg
Permeant but not impermeant divalent cations enhance activation of nondesensitizing alpha 7 nicotinic receptors
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C796 - C804.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics